PRKN and Cognitive impairment: Compounds such as urolithin A, actinonin, and spermidine activate PINK1/parkin - and NIX-dependent mitophagy, leading to attenuation of AD-related pathology, improved mitochondrial function, and ameliorated cognitive deficits [171,172].